Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 221 results found. Search for [ pharmaceutical manufacturers ]

Results 100 to 120 of 221
P B Jayakumar
New Delhi, January 20, 2017
The National Pharmaceutical Pricing Authority (NPPA) is seriously trying to regulate prices of stents to bring down angioplasty costs.


Dr Suresh Surana
New Delhi, January 18, 2017
It needs to be seen whether the government takes a populist approach or a business friendly and growth oriented approach. Here are some of the industry expectations particularly from income tax perspective from this year's budget.


By E. Kumar Sharma,E Kumar Sharma
Delhi, October 29, 2016
Many major pharma stocks, seen as safe bets in the worst of times, have seen their market caps slip in the past year. Is pharma losing its sheen on the bourses?


E Kumar Sharma
October 10, 2016
Leading global consultancy firms like Lachman Consultants, Parexel and Quintiles (now QuintilesIMS), have been in demand in India with pharmaceutical companies seeking their services to resolve regulatory compliance issues.


Reuters
September 29, 2016
A short drive from the bustling tech hub of Hyderabad, Medak is the heart of India's antibiotics manufacturing business: a district of about 2.5 million that has become one of the world's largest suppliers of cheap drugs to most markets, including the United States.


By E. Kumar Sharma
Delhi, September 25, 2016
There are lessons for Indian pharma companies from the drug pricing concerns in the US.


By Chanchal Pal Chauhan
September 15, 2016
Almost all the leading global superbike makers sell in India as well: Ducati, Triumph, Indian, BMW, Moto Guzzi and Harley-Davidson. Indeed there are more brands of luxury bikes available in the country than the run-of-the-mill commuter ones.


Varun Khanna
August 22, 2016
As India strives to provide universal healthcare to its citizens, medical technology that diagnoses and treats complex NCDs is even more critical. Fortunately, India has one of the largest markets for medical devices in Asia and is poised for rapid growth.


PTI
New Delhi, August 19, 2016
\"NPPA has fixed/revised ceiling prices of 22 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013,\" the National Pharmaceutical Pricing Authority (NPPA) said in a statement.


Chanchal Pal Chauhan
August 18, 2016
The spiralling growth of Indian automobile industry has also led to an increase in the notorious counterfeiting business.


By E Kumar Sharma
Delhi, August 19, 2016
The fact that the $8-billion Fosun Group was keen on the US market makes the deal special, given that 62 per cent of Gland Pharma's revenues of $169 million in 2015 came from the US, compared to 16 per cent from India and the rest from other geographies.


Neetu Chandra Sharma
August 3, 2016
The ministry has appealed the drug manufacturers to get the 'good quality' tag for easy export of their medicines.


By PB Jayakumar
Delhi, July 23, 2016
India's internet pharmacies are seeing their businesses shrink and struggle in the face of myriad hurdles.


PTI
New Delhi, June 22, 2016
The Union Cabinet on Wednesday decided to withdraw the Drugs and Cosmetics (Amendment) Bill, 2013, which had been introduced in the Rajya Sabha. A Standing Committee of Parliament had made a number of recommendations for changing the provisions of the Bill.


E Kumar Sharma
June 20, 2016
The new policy on foreign direct investment (FDI) announced by the government on Monday, June 20, has been welcomed by the Indian pharma sector, though there are some caveats being added in terms of the likely responses to the policy from foreign companies.


PTI
New Delhi, June 10, 2016
Currently, FDI up to 100 per cent is permitted in new projects in the pharmaceutical sector, but in brownfield ones-the existing companies-the foreign investment is permitted through FIPB approval.


PTI
New Delhi, June 6, 2016
Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.


E Kumar Sharma
June 3, 2016
\"Real, meaningful progress remains elusive, and recent signals indicate backsliding in key areas. For instance, India just released its long-awaited National Intellectual Property Rights Policy, which falls far short of industry expectations.\"


E Kumar Sharma
May 17, 2016
During this week, at the National Institute of Biologicals at Noida, Delhi, about 65 specially trained officials, including state regulators, those from drug testing laboratories and from the CDSCO (Central Drugs Standard Control Organisation) held meetings with senior and experienced regulators.


E Kumar Sharma
May 15, 2016
Some are not sure if the amendments in the policy that are being proposed are being done without an amendment to the Patent Act but through a notification on amendment of rules. There is still need for clarity on this.


PAGES 6 OF 12  678910